Optomed PLC Market Cap ($32.43 Million)
Market Cap & Net Worth: Optomed PLC (OPTOMED)
Optomed PLC market cap. Optomed PLC (HE:OPTOMED) has a market capitalization of $32.43 Million (€27.74 Million) as of October 31, 2026. Listed on the HE stock exchange, this Finland-based company holds position #23304 globally and #118 in its home market, demonstrating a 1.59% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Optomed PLC's stock price €1.41 by its total outstanding shares 19671255 (19.67 Million).
Optomed PLC Market Cap History (2019–2026)
Optomed PLC market cap history from 2019 to 2026. Data shows change from $145.81 Million to $32.43 Million (-15.68% CAGR). Check Optomed PLC stock price for real-time trading data and today's change.
Optomed PLC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Optomed PLC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see OPTOMED cash generation efficiency for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
7.13x
Optomed PLC's market cap is 7.13 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $145.81 Million | $14.98 Million | -$2.88 Million | 9.74x | N/A |
| 2020 | $166.04 Million | $13.01 Million | -$3.18 Million | 12.76x | N/A |
| 2021 | $225.38 Million | $14.85 Million | -$4.25 Million | 15.18x | N/A |
| 2022 | $86.13 Million | $14.66 Million | -$5.47 Million | 5.87x | N/A |
| 2023 | $84.52 Million | $15.10 Million | -$4.44 Million | 5.60x | N/A |
| 2024 | $107.17 Million | $15.04 Million | -$5.45 Million | 7.13x | N/A |
Competitor Companies of OPTOMED by Market Capitalization
Companies near Optomed PLC in the global market cap rankings as of October 31, 2026. See net asset quality index of Optomed PLC to understand what proportion of total assets are financed by equity.
Key companies related to Optomed PLC by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #719 globally with a market cap of $37.44 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1627 globally with a market cap of $14.50 Billion USD ( AU$20.50 Billion AUD).
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2005 globally with a market cap of $11.06 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2067 globally with a market cap of $10.63 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #719 | Veeva Systems Inc Class A | NYSE:VEEV | $37.44 Billion | $312.96 |
| #1627 | Pro Medicus Ltd | AU:PME | $14.50 Billion | AU$196.20 |
| #2005 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $11.06 Billion | $72.22 |
| #2067 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $66.89 |
Market Capitalization of Optomed PLC (2019–2026)
Market capitalization of Optomed PLC from 2019 to today. Between 2019 and today, Optomed PLC's market cap moved from $145.81 Million to $ 32.43 Million, with a yearly change of -15.68%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €32.43 Million | -62.60% |
| 2025 | €86.70 Million | -19.10% |
| 2024 | €107.17 Million | +26.80% |
| 2023 | €84.52 Million | -1.87% |
| 2022 | €86.13 Million | -61.79% |
| 2021 | €225.38 Million | +35.73% |
| 2020 | €166.04 Million | +13.88% |
| 2019 | €145.81 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Optomed PLC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $32.43 Million USD |
| MoneyControl | $32.43 Million USD |
| MarketWatch | $32.43 Million USD |
| marketcap.company | $32.43 Million USD |
| Reuters | $32.43 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Optomed PLC
Optomed Oyj, together with its subsidiaries, manufactures and sells handheld fundus cameras in Finland, rest of Europe, and internationally. The company operates in two segments, Devices and Software. It develops, manufactures, and sells fundus cameras for ophthalmologists, pediatricians, endocrinologists, neurologists, and primary health care professionals; and provides professional IT consultin… Read more